P. Aguilera

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma

M. Pajares, A. Hernández-Laín, P. Sánchez-Gómez, 2015, Molecular Cancer Therapeutics.